Newsfeeds - Spark Newswire

2 minute read

SciSparc Announces Additional Results From The Third Part Of Clearmind Medicine Inc. Pre-Clinical Study For Cocaine Addiction Treatment

Today, 5:54 PM

The results of pre-clinical in-vivo research studies suggested that Clearmind's drug candidate MEAI may be effective in the treatment of addiction without interrupting the natural reward process. TEL AVIV, Israel,

SPRC

2 minute read

This Original Psychedelic-Based Obesity Treatment Set To First-In-Human Trials

By Lara Goldstein

Today, 5:54 PM

Psychedelics biopharma company Clearmind Medicine Inc. (NASDAQ: CMND) and clinical-stage firm SciSparc Ltd.

CMND

1 minute read

SciSparc Signs Non-Binding LOI To Sell A 50% Interest In Its Subsidiary That Owns Wellution

By Vuk Zdinjak

Today, 5:54 PM

SciSparc Ltd. (NASDAQ: SPRC) has entered into a non-binding letter of intent for the sale of a 50% interest in its wholly owned subsidiary, SciSparc Nutraceuticals Inc., which owns Wellution, to Jeffs' Brands Ltd. (NASD

AMZN

2 minute read

SciSparc Announces Study Results With SCI-210, A Cannabidiol-Based Treatment For Epilepsy

By Benzinga Newsdesk

Today, 5:54 PM

The non- clinical study was conducted at The Chaim Sheba Medical Center in Israel Tel-Aviv, Dec. 07, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC), a specialty, clinical-stage pharmaceutical company focusing on

SPRC

1 minute read

Jeffs’ Brands Joins Hand With SciSparc For New Line Of Products

By Shivani Kumaresan

Today, 5:54 PM

Jeffs’ Brands Ltd (NASDAQ:JFBR) has entered into a letter of intent (LOI) with SciSparc Ltd (NASDAQ:SPRC), a specialty pharmaceutical and food supplements company,…

JFBR

2 minute read

Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket

By Lisa Levin

Today, 5:54 PM

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run.

AMBO

1 minute read

SciSparc Completes Acquisition Of Wellution

By Benzinga Newsdesk

Today, 5:54 PM

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,

SPRC

2 minute read

SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes

By Vuk Zdinjak

Today, 5:54 PM

SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisional patent application related to metabolic syndromes including obesity, regarding the company's collaboration with Clearmind.

CMNDF

6 minute read

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:54 PM

Gainers

ADBE

4 minute read

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 5:54 PM

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.

ADBE